Galectin-3 expression in papillary thyroid carcinoma: Relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size

Head and Neck

Volumn 27, Issue 12, 2005, Pages 1049-1055

  Cvejic, Dubravka S ^a   Savin, Svetlana B ^a   Petrovic, Ivana M ^a   Paunovic, Ivan R ^b   Tatic, Svetislav B ^c   Havelka, Marija J ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Galectin 3; Immunohistochemistry; Papillary carcinoma; Thyroid; Tumor marker

Indexed keywords

GALECTIN 3; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

EID: 28244477073     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20276     Document Type: Article

References (38)

1. Barondes SH, Cooper DVW, Gitt MA, Leffler H. Galectins: structure and function of a large family of animal lectins. J Biol Chem 1994;69:20807-20810.
2. Leffler H. Galectins: structure and function-a synopsis. Results Probl Cell Differ 2001;33:57-83.
3. Krzeslak A, Lipinska A. Galectin-3 as a multifunctional protein. Cell Mol Biol Lett 2004;9:305-328.
4. Yang RY, Liu FT. Galectins in cell growth and apoptosis. Cell Mol Life Sci 2003;60:267-276.
5. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation and cell death. J Mol Med 1998;76:402-412.
6. Hughes RC. Galectins as modulators of cell adhesion. Biochimie 2001;83:667-676.
7. Liu FT. Galectins: a new family of regulators of inflammation. Clin Immunol 2000;97:79-88.
8. Dagher SF, Wang JL, Patterson RJ. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci U S A 1995;92:1213-1217.
9. Danguy A, Camby I, Kiss R. Galectins and cancer. Biochem Biophys Acta 2002;1572:285-293.
10. Van den Brule F, Califice S, Castronovo V. Expressions of galectins in cancer: a critical review. Glycoconj J 2004;19:537-542.
11. Takenaka Y, Fukumori T, Raz A. Galectin-3 and metastasis. Glycoconj J 2004;19:543-549.
12. Xu XC, El-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 1995;147:815-822.
13. Fernandez PL, Merino MJ, Gomez M, et al. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 1997;181:80-86.
14. Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 1998;18:2637-2642.
15. Orlandi F, Saggiorato E, Pivano G, et al. Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 1998;58:3013-3020.
16. Inohara H, Honjo Y, Yoshii T, et al. Expression of galectin-3 in fine needle aspirates as a differential diagnostic marker between benign and malignant thyroid neoplasms. Cancer 1999;85:2475-2484.
17. Kawachi K, Yoshifumi M, Yonezawa S, et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol 2000;31:428-433.
18. Cvejic D, Savin S, Golubovic S, Paunovic I, Tatic S, Havelka M. Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumour progression. Histopathology 2000;37:530-535.
19. Bartolazzi A, Gasbari A, Papotti M, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001;357:1644-1650.
20. Saggiorato E, Cappia S, De Giuli P, et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 2001;86:5152-5158.
21. Nascimento MC, Bisi H, Alves V, Longatto-Filho A, Kanamura C, Medeiros-Neto G. Differential reactivity for galectin-3 in Hurthle cell adenomas and carcinomas. Endocrine Pathology 2001;12:275-279.
22. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 2002;40:80-87.
23. Herrmann ME, LiVolsi V, Pasha T, Roberts SA, Wojcik EM, Baloch ZW. Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 2002;6:710-713.
24. Kovács RB, Földes J, Winkler G, Bodó M, Sápi Z. The investigation of galectin-3 in diseases of the thyroid gland. Eur J Endocrinol 2003;149:449-453.
25. Feilchenfeldt J, Tötsch M, Sheu S, et al. Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry. Mod Pathol 2003;16:1117-1123.
26. Giannini R, Faviana P, Cavinato T, et al. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasms as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens. Thyroid 2003;13:765-770.
27. Savin S, Cvejic D, Jankovic M. Expression of galectin-1 and galectin-3 in human fetal thyroid gland. J Histochem Cytochem 2003;51:479-483.
28. Saggiorato E, Aversa S, Deandreis D, et al. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas. J Endocrinol Invest 2004;27:311-317.
29. Volante M, Bozzalla-Cassione F, Orlandi F, Papotti M. Diagnostic role of galectin-3 in follicular thyroid tumors. Virchows Arch 2004;444:309-312.
30. Weber KB, Shroyer KR, Heinz DE, Nawaz SN, Sherif Said M, Haugen BR. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer. Am J Clin Pathol 2004;122:524-531.
31. Oestreicher-Kedem Y, Halpern M, Roizman P, et al. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions. Head Neck 2004;26:960-969.
32. Carcangiu ML, Zampi G, Rosai J. Papillary thyroid carcinoma: a study of its many morphologic expressions and clinical correlates. Pathol Ann 1985;20:1-44.
33. Li Volsi A. Surgical pathology of the thyroid. Philadelphia: Saunders; 1990.
34. Rosai J, Carcangiu ML, Delellis RA. Tumors of the thyroid gland. In: Rosai J, Carcangiu ML, Delellis RA, editors. Atlas of tumor pathology, third series, vol. 5. Washington, DC: Armed Forces Institute of Pathology; 1992. p 65-159.
35. Rosai J. Thyroid gland. In: Rosai J, editor. Ackerman's surgical pathology, 8th ed. Sydney: Mosby; 1996. p 493-567.
36. Mizukami Y, Michigishi T, Nonomura A, Noguchi M, Nakamura H. Thyroid carcinoma: clinical, pathologic correlations. Crit Rev Oncol/Hematol 1995;18:67-102.
37. Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A. Pure versus follicular variant of papillary thyroid carcinoma. Clinical features, prognostic factors, treatment and survival. Cancer 2003;97:1181-1185.
38. th ed. Berlin, Heidelberg, New York: Springer Verlag; 1987.